Cover Image
close this bookGuidelines for the WHO Review of Dependence-Producing Psychoactive Substances for International Control (WHO/EDM, 2000, 22 p.)
View the document(introductory text...)
View the documentI. Mandate
View the documentII. Underlying principles
View the documentIII. Provisions of the conventions
Open this folder and view contentsVI. WHO review procedure
View the documentV. Communication of WHO recommendations
View the documentVI. Publication of documents related to the WHO review
View the documentVII. Abbreviations and definitions
View the documentAppendix 1: Excerpts from the UN drug control conventions
View the documentAppendix 2: Resolution 1(S-VIII) of the United Nations Commission on Narcotic Drugs1

I. Mandate

1. The World Health Organization (WHO) is the specialized agency designated for the evaluation of the medical, scientific and public health aspects of psychoactive substances under the Single Convention on Narcotic Drugs, 1961 (the 1961 Convention), as amended by the 1972 Protocol, and the Convention on Psychotropic Substances, 1971 (the 1971 Convention). A procedure for this assessment has been developed pursuant to resolutions of the Health Assembly and of the United Nations Commission on Narcotic Drugs (CND). This document sets out guidelines dealing with the underlying principles of the review procedure, working arrangements within the WHO Secretariat and with external bodies, and the nature of the documentation to be prepared. The guidelines cover WHO's responsibilities under Article 3 of the 1961 Convention and Article 2 of the 1971 Convention concerning whether or not to recommend international control of substances, as well as the assessment of exempted preparations under Article 3 of the 1971 Convention. Common terms and abbreviations are listed in Section VII.

2. The Thirty-third World Health Assembly, by resolution WHA33.27 (1980), requested the Director-General "to promote the initiation and strengthening of national and international programmes for the assessment, scheduling, control and appropriate use of narcotic and psychotropic substances including those of plant origin, and to support such programmes by the development of appropriate guidelines", and further "to strengthen the coordination between the WHO programmes relating to narcotic and psychotropic substances, those dealing with drug policy and management, and other related programmes, and to strengthen collaboration with interested nongovernmental organizations".

3. In the light of experience gained over later years, and following the guidance of the Executive Board1, WHO developed a procedure for the evaluation and assessment of narcotic and psychotropic substances for decisions on international control in consultation with CND in 19862, which was revised in 19903. Amendments and decisions subsequently adopted by the Executive Board in 19944 and 19995 have laid the foundation for another revision of the procedure as presented in this document.

1 Resolution EB73.R11.
2 Decision EB77(3).
3 Decision EB85(10).
4 Decision EB93(16).
5 Decision EB103(5).